Olajossy, B.; Wronski, N.; Madej, E.; Komperda, J.; Szczygieł, M.; Wolnicka-Glubisz, A.
RIPK4 Downregulation Reduces ABCG2 Expression, Increasing BRAF-Mutated Melanoma Cell Susceptibility to Cisplatin- and Doxorubicin-Induced Apoptosis. Biomolecules 2024, 14, 1573.
https://doi.org/10.3390/biom14121573
AMA Style
Olajossy B, Wronski N, Madej E, Komperda J, Szczygieł M, Wolnicka-Glubisz A.
RIPK4 Downregulation Reduces ABCG2 Expression, Increasing BRAF-Mutated Melanoma Cell Susceptibility to Cisplatin- and Doxorubicin-Induced Apoptosis. Biomolecules. 2024; 14(12):1573.
https://doi.org/10.3390/biom14121573
Chicago/Turabian Style
Olajossy, Bartlomiej, Norbert Wronski, Ewelina Madej, Joanna Komperda, Małgorzata Szczygieł, and Agnieszka Wolnicka-Glubisz.
2024. "RIPK4 Downregulation Reduces ABCG2 Expression, Increasing BRAF-Mutated Melanoma Cell Susceptibility to Cisplatin- and Doxorubicin-Induced Apoptosis" Biomolecules 14, no. 12: 1573.
https://doi.org/10.3390/biom14121573
APA Style
Olajossy, B., Wronski, N., Madej, E., Komperda, J., Szczygieł, M., & Wolnicka-Glubisz, A.
(2024). RIPK4 Downregulation Reduces ABCG2 Expression, Increasing BRAF-Mutated Melanoma Cell Susceptibility to Cisplatin- and Doxorubicin-Induced Apoptosis. Biomolecules, 14(12), 1573.
https://doi.org/10.3390/biom14121573
